Biomedical Engineering Reference
In-Depth Information
FURTHER READINGS
Altmann KH and Gertsch J (2007) Anticancer drugs from nature-natural products as a unique source of new
microtubule-stabilizing agents.
Nat Prod Rep
24:327-357.
Costi MP, Ferrari S, Venturelli A, Calo S, Tondi D, and Barlocco D (2005) Thymidylate synthase structure,
function and implication in drug discovery.
Curr Med Chem
12:2241-2258.
DeVita VT, Jr, Hellman S, and Rosenberg SA (2005)
Cancer: Princples and Practice of Oncology
, 7th edn.
Lipincott Williams & Wilkins ISBN 0-781-74450-4.
Hanahan D and Weinberg RA (2000) The hallmarks of cancer.
Cell
100:57-70.
Hudis CA (2007) Trastuzumab-mechanism of action and use in clinical practice.
N Engl J Med
357:39-51.
Kastan MB and Bartek J (2004) Cell-cycle checkpoints and cancer.
Nature
432:316-323.
Weisberg E, Manley PW, Cowan-Jacob SW, Hochhaus A, and Grifi n JD (2007) Second generation inhibitors of
bcr-abl for the treatment of imatinib-resistant chronic myeloid leukaemia.
Nat Rev Cancer
7:345-356.
Xu WS, Parmigiani RB, and Marks PA (2007) Histone deacetylase inhibitors: Molecular mechanisms of action.
Oncogene
26:5541-5552.